• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

megan.lim@unimelb.edu.au

Credentials


Position
Honorary (Principal Fellow)
Melbourne School of Population and Global Health - Centres and Institutes
ORCID

0000-0002-0415-2867

Ms Megan Lim

Honorary (Principal Fellow)
Melbourne School of Population and Global Health

429 Scholarly works
0 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Trends in alcohol, smoking, and drug use in cross-sectional samples of young people in Australia, 2015-24
    DOI: 10.1186/s12889-026-26353-0
  • 2026

    Journal article

    Abstract 2350: Subtype-specific patterns of peripheral T-cell lymphoma in diverse Asian populations.
    DOI: 10.1158/1538-7445.am2026-2350
  • 2026

    Journal article

    1187 Clinicopathologic and Molecular Characterization of Genetic Subtypes of ALK-Negative Anaplastic Large Cell Lymphoma (ALCL)
    DOI: 10.1016/j.labinv.2025.105479
  • 2026

    Journal article

    400 Relative Prevalence of Recurrent Gene Fusions in Primary Cutaneous CD30-positive T-cell Lymphoproliferative Disorders
    DOI: 10.1016/j.labinv.2025.104683
  • 2026

    Journal article

    Breast-implant associated unicentric castleman disease: a case report.
    DOI: 10.1016/j.cpccr.2026.100404
  • 2026

    Journal article

    1230 Identification and Characterization of B-cell Lymphomas with Concurrent Rearrangements of IRF4 and BCL2 or BCL6
    DOI: 10.1016/j.labinv.2025.105522
  • 2022

    Journal article

    "You have to drink with a little bit of shame": Alcohol and other drug use among young people from migrant and ethnic minority backgrounds in Melbourne, Australia
    DOI: 10.1080/15332640.2022.2091703
Megan Lim

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.
    DOI: 10.1182/blood.2025030976
  • 2026

    Journal article

    Complete remission of relapsed ATXN2L::JAK2 fusion positive anaplastic large cell lymphoma following ruxolitinib monotherapy in a child.
    DOI: 10.1038/s41698-026-01299-z
  • 2026

    Journal article

    Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.
    DOI: 10.1200/JCO-25-02779
  • 2026

    Journal article

    A Phase 1 Trial of Targeted Immunotherapy with Daratumumab Following Myeloablative Total Body Irradiation (TBI)-Based Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Children, Adolescents and Young Adults with High-Risk T-cell Acute Lymphoblastic Leukemia and Lymphoma (T-ALL/T-LLy) (ALLO-T-DART): A Ptctc-Facilitated Study
    DOI: 10.1016/j.jtct.2025.12.885

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224